These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 9433872

  • 1. HLA and clinical associations in systemic sclerosis patients with anti-Th/To antibodies.
    Falkner D, Wilson J, Medsger TA, Morel PA.
    Arthritis Rheum; 1998 Jan; 41(1):74-80. PubMed ID: 9433872
    [Abstract] [Full Text] [Related]

  • 2. Association of HLA class II genes with systemic sclerosis in Koreans.
    Kang SH, Park MH, Song EY, Kang SJ, Lee EB, Song YW, Takeuchi F.
    J Rheumatol; 2001 Jul; 28(7):1577-83. PubMed ID: 11469465
    [Abstract] [Full Text] [Related]

  • 3. Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin).
    Falkner D, Wilson J, Fertig N, Clawson K, Medsger TA, Morel PA.
    J Rheumatol; 2000 May; 27(5):1196-202. PubMed ID: 10813287
    [Abstract] [Full Text] [Related]

  • 4. Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain.
    Ueki A, Isozaki Y, Tomokuni A, Ueki H, Kusaka M, Tanaka S, Otsuki T, Sakaguchi H, Hyodoh F.
    Immunobiology; 2001 Dec; 204(4):458-65. PubMed ID: 11776400
    [Abstract] [Full Text] [Related]

  • 5. Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele.
    Morel PA, Chang HJ, Wilson JW, Conte C, Saidman SL, Bray JD, Tweardy DJ, Medsger TA.
    Hum Immunol; 1994 Jun; 40(2):101-10. PubMed ID: 7928439
    [Abstract] [Full Text] [Related]

  • 6. Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis.
    Gourh P, Tan FK, Assassi S, Ahn CW, McNearney TA, Fischbach M, Arnett FC, Mayes MD.
    Arthritis Rheum; 2006 Dec; 54(12):3945-53. PubMed ID: 17133608
    [Abstract] [Full Text] [Related]

  • 7. MHC class II associations with autoantibody and T cell immune responses to the scleroderma autoantigen topoisomerase I.
    Rands AL, Whyte J, Cox B, Hall ND, McHugh NJ.
    J Autoimmun; 2000 Dec; 15(4):451-8. PubMed ID: 11090244
    [Abstract] [Full Text] [Related]

  • 8. HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies.
    Morel PA, Chang HJ, Wilson JW, Conte C, Falkner D, Tweardy DJ, Medsger TA.
    Hum Immunol; 1995 Jan; 42(1):35-42. PubMed ID: 7751158
    [Abstract] [Full Text] [Related]

  • 9. HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma).
    Kuwana M, Okano Y, Kaburaki J, Inoko H.
    Ann Rheum Dis; 1995 Dec; 54(12):983-7. PubMed ID: 8546531
    [Abstract] [Full Text] [Related]

  • 10. Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma.
    Satoh M, Akizuki M, Kuwana M, Mimori T, Yamagata H, Yoshida S, Homma M, Yamamoto T, Sasazuki T.
    J Rheumatol; 1994 Jan; 21(1):111-4. PubMed ID: 8151564
    [Abstract] [Full Text] [Related]

  • 11. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y.
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [Abstract] [Full Text] [Related]

  • 12. Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases.
    Kuwana M, Kimura K, Hirakata M, Kawakami Y, Ikeda Y.
    Ann Rheum Dis; 2002 Sep; 61(9):842-6. PubMed ID: 12176814
    [Abstract] [Full Text] [Related]

  • 13. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).
    Kuwana M, Kaburaki J, Okano Y, Inoko H, Tsuji K.
    J Clin Invest; 1993 Sep; 92(3):1296-301. PubMed ID: 7690776
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis.
    Dick T, Mierau R, Bartz-Bazzanella P, Alavi M, Stoyanova-Scholz M, Kindler J, Genth E.
    Ann Rheum Dis; 2002 Feb; 61(2):121-7. PubMed ID: 11796397
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study.
    McHugh NJ, Whyte J, Artlett C, Briggs DC, Stephens CO, Olsen NJ, Gusseva NG, Maddison PJ, Black CM, Welsh K.
    Clin Exp Immunol; 1994 May; 96(2):267-74. PubMed ID: 8187334
    [Abstract] [Full Text] [Related]

  • 18. Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis.
    Kuwana M, Feghali CA, Medsger TA, Wright TM.
    Arthritis Rheum; 2001 Jul; 44(7):1654-9. PubMed ID: 11465716
    [Abstract] [Full Text] [Related]

  • 19. Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma).
    Reveille JD, Owerbach D, Goldstein R, Moreda R, Isern RA, Arnett FC.
    J Clin Invest; 1992 Apr; 89(4):1208-13. PubMed ID: 1556182
    [Abstract] [Full Text] [Related]

  • 20. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.
    Kuwana M, Kaburaki J, Arnett FC, Howard RF, Medsger TA, Wright TM.
    Arthritis Rheum; 1999 Mar; 42(3):465-74. PubMed ID: 10088769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.